• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类处方阿片类药物的滥用潜力——研究近百年回顾

The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research.

作者信息

Walsh Sharon L, Babalonis Shanna

机构信息

Department of Behavioral Science, Center on Drug and Alcohol Research, University of Kentucky, Lexington, USA.

出版信息

Curr Top Behav Neurosci. 2017;34:33-58. doi: 10.1007/7854_2016_448.

DOI:10.1007/7854_2016_448
PMID:27356522
Abstract

While opioids are very effective analgesics for treating acute pain, humans have struggled with opiate addiction for millenia. An opium abuse epidemic in the early 1900's led the US government to develop a systematic research infrastructure and scientific plan to produce new compounds with analgesic properties but without abuse liability. This review describes the techniques that were developed for testing in the human laboratory, including empirically derived outcome measures and required elements for human abuse potential assessment. The evaluation and characterization of semi-synthetic and synthetic opioids, including full mu opioid agonists, partial agonists and mixed agonist-antagonists, are described across several decades of research. Finally, the prescription opioid epidemic beginning in the 1990's in the US led to a resurgence in abuse potential evaluations, and the application of these methods to the study of novel abuse-deterrent formulations is discussed.

摘要

虽然阿片类药物是治疗急性疼痛的非常有效的镇痛药,但人类与阿片成瘾抗争已有数千年。20世纪初的阿片滥用流行促使美国政府建立了系统的研究基础设施和科学计划,以生产具有镇痛特性但无滥用倾向的新化合物。本综述描述了在人体实验室中开发的测试技术,包括根据经验得出的结果测量方法和人体滥用潜力评估所需的要素。在几十年的研究中,对半合成和合成阿片类药物进行了评估和表征,包括完全μ阿片激动剂、部分激动剂和混合激动剂-拮抗剂。最后,始于20世纪90年代美国的处方阿片类药物流行导致滥用潜力评估再次兴起,并讨论了这些方法在新型抗滥用制剂研究中的应用。

相似文献

1
The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research.人类处方阿片类药物的滥用潜力——研究近百年回顾
Curr Top Behav Neurosci. 2017;34:33-58. doi: 10.1007/7854_2016_448.
2
Opioids with abuse-deterrent properties: A regulatory and technological overview.具有滥用威慑特性的阿片类药物:监管与技术概述。
J Opioid Manag. 2017 Nov/Dec;13(6):397-413. doi: 10.5055/jom.2017.0417.
3
Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.阿片类镇痛药的使用与滥用:预防和阻止非医疗用途处方阿片类药物消费的潜在方法。
Curr Opin Investig Drugs. 2004 Jan;5(1):61-6.
4
Current and future development of extended-release, abuse-deterrent opioid formulations in the United States.美国缓释、抗滥用阿片类药物制剂的现状与未来发展
Postgrad Med. 2017 Jan;129(1):102-110. doi: 10.1080/00325481.2017.1268902. Epub 2016 Dec 12.
5
Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposure.评估阿片类滥用威慑药物(ADOs)的影响:确定与低人群暴露新使用者相关的流行病学因素。
Postgrad Med. 2017 Jan;129(1):12-21. doi: 10.1080/00325481.2017.1272397. Epub 2016 Dec 25.
6
Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.处方阿片类药物成瘾:新出现的流行情况特征及丁丙诺啡治疗
Exp Clin Psychopharmacol. 2008 Oct;16(5):435-41. doi: 10.1037/a0013637.
7
Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse.具有延迟长期拮抗活性的阿片类配体:阿片类药物滥用的潜在药物治疗方法。
Mini Rev Med Chem. 2003 Mar;3(2):137-44. doi: 10.2174/1389557033405395.
8
An evaluation method for developing abuse-deterrent opioid formulations with agonist and antagonist combinations using conditioned place preference.
Biochem Biophys Res Commun. 2023 Jan 8;639:100-105. doi: 10.1016/j.bbrc.2022.11.072. Epub 2022 Nov 30.
9
The opioid crisis: a 21st century pain.阿片类药物危机:21世纪的伤痛。
Drugs Today (Barc). 2018 Apr;54(4):283-286. doi: 10.1358/dot.2018.54.4.2812620.
10
Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification.阿片类拮抗剂、部分激动剂及激动剂/拮抗剂:门诊戒毒的作用
Pain Physician. 2008 Mar-Apr;11(2):225-35.

引用本文的文献

1
Pharmacological Characterization of Orofacial Nociception in Female Rats Following Nitroglycerin Administration.硝酸甘油给药后雌性大鼠口腔面部伤害感受的药理学特征
Front Pharmacol. 2020 Dec 3;11:527495. doi: 10.3389/fphar.2020.527495. eCollection 2020.
2
Individual differences in human opioid abuse potential as observed in a human laboratory study.人类实验室研究中观察到的人类阿片类药物滥用潜力的个体差异。
Drug Alcohol Depend. 2019 Dec 1;205:107688. doi: 10.1016/j.drugalcdep.2019.107688. Epub 2019 Oct 28.
3
A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans.
曲马多对人类潜在滥用可能性的实验室证据的系统评价
Front Psychiatry. 2019 Sep 26;10:704. doi: 10.3389/fpsyt.2019.00704. eCollection 2019.
4
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.纳呋拉啡作为一种阿片类药物节约辅助药物的临床前测试,该药物通过靶向μ阿片受体的激动剂吗啡增强镇痛作用。
J Pharmacol Exp Ther. 2019 Nov;371(2):487-499. doi: 10.1124/jpet.118.255661. Epub 2019 Sep 6.
5
Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis science.甜美的花儿开得慢,野草却长得快:借鉴烟草、酒精和阿片类镇痛药研究中的方法学,在大麻科学领域取得快速且与政策相关的进展。
Int Rev Psychiatry. 2018 Jun;30(3):238-250. doi: 10.1080/09540261.2018.1465400.
6
The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward?慢性疼痛中使用阿片类药物出现问题的风险:我们能从疼痛与奖赏的研究中学到什么?
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):255-262. doi: 10.1016/j.pnpbp.2017.07.029. Epub 2017 Aug 1.